If you didn’t believe a prevailing scientific position, you used to be part of a small fringe. To get information on your side, you would hunt around a certain type of bookshop, and subscribe to newsletters with
Many trials end with a whimper. But some end with a bang. Press release, press conference, lots of fanfare – and backlash. The drama of another clinical trial being stopped early burst into public
The potential harms of interventions are tricky to get a handle on. Our feelings about them are, too. It wouldn’t be easy – even if we didn’t have to deal with people trying to
It all starts and ends with the patient. That was a strong message from the first day of Evidence Live. Trisha Greenhalgh walked that walk on day 2. She showed the limits of evidence-based medicine (EBM) with
P is for pandemonium. And a bit of that broke out recently when a psychology journal banned p–values and more, declaring the whole process of significance testing “invalid”. There’s a good roundup of views about this development from
Guest post by Michelle Munyikwa I recently read this article in Health Affairs regarding the effects of the hidden curriculum on patient safety and, in my usual fashion, have been thinking about it ever since.